相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Is the 3+3 Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design
Osama E. Rahma et al.
CLINICAL CANCER RESEARCH (2014)
Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
Robert O. Dillman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Improved Time to Progression for Transarterial Chemoembolization Compared With Transarterial Embolization for Patients With Unresectable Hepatocellular Carcinoma
Michael A. Morse et al.
CLINICAL COLORECTAL CANCER (2012)
Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy: A Randomized Phase II Trial of Dendritic Cells Versus Tumor Cells in Patients With Metastatic Melanoma
Robert O. Dillman et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
Timothy M. Pawlik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique
Mark J. Truty et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Recent advances in the treatment of hepatocellular carcinoma
Amit G. Singal et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
Mustafa S. Ascha et al.
HEPATOLOGY (2010)
Establishment of stable cell lines for personalized melanoma cell vaccine
Senthamil R. Selvan et al.
MELANOMA RESEARCH (2010)
Is There a Role for Adjuvant Treatment after Hepatic Resection for Hepatocellular Carcinoma?
Ann Tan et al.
ONCOLOGY (2010)
Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report
Robert O. Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Treatment of large and advanced hepatocellular carcinoma
Eddie K. Abdalla et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Liver transplantation for hepatocellular carcinoma
Vincenzo Mazzaferro et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients
Jing-Houng Wang et al.
EUROPEAN JOURNAL OF CANCER (2008)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Overview of the MELD score and the UNOS adult liver allocation system
A. P. Martin et al.
TRANSPLANTATION PROCEEDINGS (2007)
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: Validation of a uniform staging after surgical treatment
Jean-Nicolas Vauthey et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Prospective validation of the Barcelona Clinic Liver Cancer staging system
U Cillo et al.
JOURNAL OF HEPATOLOGY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score
M Kudo et al.
HEPATOLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic cancer: Induction of delayed-type hypersensitivity to autologous tumor is associated with improved survival
RO Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2002)
分享论文
